Search Results - "Farías, Gonzalo A"

Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches by Morales, Inelia, Guzmán-Martínez, Leonardo, Cerda-Troncoso, Cristóbal, Farías, Gonzalo A, Maccioni, Ricardo B

“…Alzheimer disease (AD) is the most common cause of dementia in people over 60 years old. The molecular and cellular alterations that trigger this disease are…”
Get full text

Biomarkers for dementia in Latin American countries: Gaps and opportunities by Parra, Mario A., Orellana, Paulina, Leon, Tomas, Victoria, Cabello G., Henriquez, Fernando, Gomez, Rodrigo, Avalos, Constanza, Damian, Andres, Slachevsky, Andrea, Ibañez, Agustin, Zetterberg, Henrik, Tijms, Betty M., Yokoyama, Jennifer S., Piña‐Escudero, Stefanie D., Cochran, J. Nicholas, Matallana, Diana L., Acosta, Daisy, Allegri, Ricardo, Arias‐Suárez, Bianca P., Barra, Bernardo, Behrens, Maria Isabel, Brucki, Sonia M. D., Busatto, Geraldo, Caramelli, Paulo, Castro‐Suarez, Sheila, Contreras, Valeria, Custodio, Nilton, Dansilio, Sergio, Cruz‐Puebla, Myriam De, Souza, Leonardo Cruz, Diaz, Monica M., Duque, Lissette, Farías, Gonzalo A., Ferreira, Sergio T., Guimet, Nahuel Magrath, Kmaid, Ana, Lira, David, Lopera, Francisco, Meza, Beatriz Mar, Miotto, Eliane C., Nitrini, Ricardo, Nuñez, Alberto, O'Neill, Santiago, Ochoa, John, Pintado‐Caipa, Maritza, Resende, Elisa de Paula França, Risacher, Shannon, Rojas, Luz Angela, Sabaj, Valentina, Schilling, Lucas, Sellek, Allis F., Sosa, Ana, Takada, Leonel T., Teixeira, Antonio L., Unaucho‐Pilalumbo, Martha, Duran‐Aniotz, Claudia

“…Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC) countries remains a serious barrier. Here, we reported a survey to explore the…”
Get full text

The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population by Guzmán-Martínez, Leonardo, Tapia, José Pablo, Farías, Gonzalo A, González, Andrea, Estrella, Matías, Maccioni, Ricardo B

“…The establishment of a molecular biomarker for early detection of Alzheimer's disease (AD) is critical for diagnosis and follow up of patients, and as a…”
Get more information

Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease by Slachevsky, Andrea, Guzmán-Martínez, Leonardo, Delgado, Carolina, Reyes, Pablo, Farías, Gonzalo A, Muñoz-Neira, Carlos, Bravo, Eduardo, Farías, Mauricio, Flores, Patricia, Garrido, Cristian, Becker, James T, López, Oscar L, Maccioni, Ricardo B

“…Intracellular neurofibrillary tangles are part of the core pathology of Alzheimer's disease (AD), which are mainly composed of hyperphosphorylated tau protein…”
Get more information

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss by Medel, Vicente, Delano, Paul H., Belkhiria, Chama, Leiva, Alexis, De Gatica, Cristina, Vidal, Victor, Navarro, Carlos F., Martín, Simon San, Martínez, Melissa, Gierke, Christine, García, Ximena, Cerda, Mauricio, Vergara, Rodrigo, Delgado, Carolina, Farías, Gonzalo A.

“…INTRODUCTION Age‐related hearing loss is an important risk factor for cognitive decline. However, audiogram thresholds are not good estimators of dementia risk…”
Get full text

Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders by Farías, Gonzalo A, Guzmán-Martínez, Leonardo, Delgado, Carolina, Maccioni, Ricardo B

“…Alzheimer's disease is a growing health problem worldwide. The pharmaceutical industry has not recently developed any new drugs that have had a significant…”
Get more information

Can Nutraceuticals Prevent Alzheimer's Disease? Potential Therapeutic Role of a Formulation Containing Shilajit and Complex B Vitamins by Carrasco-Gallardo, Carlos, Farías, Gonzalo A, Fuentes, Patricio, Crespo, Fernando, Maccioni, Ricardo B

“…Alzheimer's disease (AD) is a brain disorder displaying a prevalence and impact in constant expansion. This expansive and epidemic behavior is concerning…”
Get full text

Retrospective Diagnosis of Parkinsonian Syndromes Using Whole-Brain Atrophy Rates by Guevara, Carlos, Bulatova, Kateryna, Soruco, Wendy, Gonzalez, Guido, Farías, Gonzalo A

“…The absence of markers for diagnosis of idiopathic Parkinson's disease (IPD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) results…”
Get full text

Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs by Guzmán-Martinez, Leonardo, Farías, Gonzalo A, Maccioni, Ricardo Benjamin

“…A cumulative number of approaches have been carried out to elucidate the pathogenesis of Alzheimer's disease (AD). Tangles formation has been identified as a…”
Get full text

Prospective Assessment of No Evidence of Disease Activity-4 Status in Early Disease Stages of Multiple Sclerosis in Routine Clinical Practice by Guevara, Carlos, Garrido, Cristian, Martinez, Melissa, Farias, Gonzalo A, Orellana, Patricia, Soruco, Wendy, Alarcón, Pablo, Diaz, Violeta, Silva, Carlos, Kempton, Matthew J, Barker, Gareth, de Grazia, José

“…In relapsing-remitting multiple sclerosis, no evidence of disease activity-3 (NEDA-3) is defined as no relapses, no disability progression and no MRI activity…”
Get full text

Emerging Noninvasive Biomarkers for Early Detection of Alzheimer's Disease by Guzmán-Martínez, Leonardo, Farías, Gonzalo A, Maccioni, Ricardo B

“…Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsychological testing. The development of accurate, easy to use and…”
Get full text